Evidence map›Paper›PMID 28924182›Full record

ArticleMolecular psychiatry2018

An in vitro model of lissencephaly: expanding the role of DCX during neurogenesis.

M Shahsavani, R J Pronk, R Falk, M Lam, M Moslem, S B Linker, J Salma, K Day, J Schuster, B-M Anderlid and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. iPSCs-Derived Neurons and Brain Organoids from Patients.Handbook of experimental pharmacology · 2023
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

M ShahsavaniDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
R J PronkDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
R FalkDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
M LamDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
M MoslemDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
S B LinkerLaboratory of Genetics, Salk Institute for Biological Studies, La Jolla, CA, USA.
J SalmaDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
K DayDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
J SchusterScience for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
B-M AnderlidDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
N DahlScience for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
F H GageLaboratory of Genetics, Salk Institute for Biological Studies, La Jolla, CA, USA.
A FalkDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden. Anna.falk@ki.se.
Karolinska Institutet · SESalk Institute for Biological Studies · USKarolinska University Hospital · SEScience for Life Laboratory · SEUppsala University · SE

Funding

Role of CACNA1C - a shared risk gene in neuropsychiatric disordersU19MH106434 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI SONG, HONGJUN · 2016 to 2020
$13.8M
Single-Cell Approaches to Reveal How Jumping Genes Individualize Neural CircuitsR01MH095741 · NIMH · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI GAGE, FRED H · 2011 to 2015
$6.5M
NIMH NIH HHS R01 MH095741NIMH NIH HHS U19 MH106434
6 · The paper itself

Abstract

Lissencephaly comprises a spectrum of brain malformations due to impaired neuronal migration in the developing cerebral cortex. Classical lissencephaly is characterized by smooth cerebral surface and cortical thickening that result in seizures, severe neurological impairment and developmental delay. Mutations in the X-chromosomal gene DCX, encoding doublecortin, is the main cause of classical lissencephaly. Much of our knowledge about DCX-associated lissencephaly comes from post-mortem analyses of patient's brains, mainly since animal models with DCX mutations do not mimic the disease. In the absence of relevant animal models and patient brain specimens, we took advantage of induced pluripotent stem cell (iPSC) technology to model the disease. We established human iPSCs from two males with mutated DCX and classical lissencephaly including smooth brain and abnormal cortical morphology. The disease was recapitulated by differentiation of iPSC into neural cells followed by expression profiling and dissection of DCX-associated functions. Here we show that neural stem cells, with absent or reduced DCX protein expression, exhibit impaired migration, delayed differentiation and deficient neurite formation. Hence, the patient-derived iPSCs and neural stem cells provide a system to further unravel the functions of DCX in normal development and disease.

Indexed as

BrainCell DifferentiationCell MovementCells, CulturedCerebral CortexDoublecortin Domain ProteinsDoublecortin ProteinFibroblastsHumansInduced Pluripotent Stem CellsInfantInfant, NewbornLissencephalyMaleMicrotubule-Associated ProteinsNeural Stem CellsDCX protein, humanDoublecortin Domain ProteinsDoublecortin ProteinMicrotubule-Associated ProteinsNeuropeptides

Identifiers

PMID28924182
OpenAlexW2754676964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.